Despite the controversial role of NOX4 in tumor progression, including the enhancement of prostate cancer cell progression but inhibition of liver cancer cell proliferation 18,20, we found that increased NOX4 levels were associated with the poor survival rates of CRC patients and with tumor metastasis. Here, NOX4 is linked to prostate carcinoma.